KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cognex (CGNX) Other Non-Current Assets (2016 - 2025)

Cognex (CGNX) has disclosed Other Non-Current Assets for 17 consecutive years, with $5.0 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Other Non-Current Assets fell 0.66% year-over-year to $5.0 million, compared with a TTM value of $5.0 million through Dec 2025, down 0.66%, and an annual FY2025 reading of $5.0 million, down 0.66% over the prior year.
  • Other Non-Current Assets was $5.0 million for Q4 2025 at Cognex, down from $5.3 million in the prior quarter.
  • Across five years, Other Non-Current Assets topped out at $7.7 million in Q2 2021 and bottomed at $5.0 million in Q4 2025.
  • Average Other Non-Current Assets over 5 years is $6.4 million, with a median of $6.6 million recorded in 2022.
  • Peak annual rise in Other Non-Current Assets hit 11.2% in 2024, while the deepest fall reached 29.08% in 2024.
  • Year by year, Other Non-Current Assets stood at $7.2 million in 2021, then decreased by 8.27% to $6.6 million in 2022, then grew by 6.7% to $7.1 million in 2023, then fell by 29.08% to $5.0 million in 2024, then dropped by 0.66% to $5.0 million in 2025.
  • Business Quant data shows Other Non-Current Assets for CGNX at $5.0 million in Q4 2025, $5.3 million in Q3 2025, and $5.3 million in Q2 2025.